A randomised, single blind, three-way cross-over, single-centre study to assess the pharmacodynamics (intragastric pH) and pharmacokinetics after repeated oral administration of D961H 20 and 40 mg, and omeprazole 20 mg in Japanese healthy male subjects

Study identifier:D961HC00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A randomised, single blind, three-way cross-over, single-centre study to assess the pharmacodynamics (intragastric pH) and pharmacokinetics after repeated oral administration of D961H 20 and 40 mg, and omeprazole 20 mg in Japanese healthy male subjects

Medical condition

gastrointestinal diseases

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jun 2007
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria